Eris Lifesciences Ltd - 540596 - Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation
INTIMATION OF SCHEDULE OF ANALYST / INSTITUTIONAL INVESTOR MEETING DATED 19TH JANUARY, 2022.19-01-2022
19-01-2022
Eris Lifesciences Ltd - 540596 - Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation
INTIMATION OF SCHEDULE OF ANALYST / INSTITUTIONAL INVESTOR MEETING DATED 18TH JANUARY,2022.18-01-2022
Eris Lifesciences Ltd - 540596 - Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation
INTIMATION OF SCHEDULE OF ANALYST / INSTITUTIONAL INVESTOR MEETING DATED 13TH JANUARY, 2022.13-01-2022
Eris Lifesciences Ltd - 540596 - Announcement under Regulation 30 (LODR)-Updates on Joint Venture
UPDATE ON 'ANNOUNCEMENT UNDER REGULATION 30 (LODR) - JOINT VENTURE'13-01-2022
Eris Lifesciences Q3 PAT seen up 12.4% YoY to Rs 101.4 cr: Prabhudas Lilladher
Net Sales are expected to increase by 11.9 percent Y-o-Y (down 3.5 percent Q-o-Q) to Rs 347.2 crore, according to Prabhudas Lilladher.13-01-2022
Eris Lifesciences Ltd - 540596 - Statement Of Investor Complaints For The Quarter Ended December 2021
No.of Investor complaints pending at the beginning of the quarter No.of Investor complaints received during the quarter No.of Investor complaints disposed of during the quarter No.of Investor complaints unresolved at the end of the quarter 0000 Name of the Signatory :- MILIND TALEGAONKARDesignation :- Company Secretary and Compliance Officer11-01-2022
Eris Lifesciences Ltd - 540596 - Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation
INTIMATION OF SCHEDULE OF ANALYST / INSTITUTIONAL INVESTOR MEETING ON 7TH JANUARY, 202207-01-2022
Eris Lifesciences Ltd - 540596 - Closure of Trading Window
INTIMATION OF CLOSURE OF TRADING WINDOW FROM 1ST JANUARY, 202231-12-2021
Eris Lifesciences Ltd - 540596 - Reply To The Clarification Sought
This is with reference to Corporate announcement section of our Company on the portal of BSE seeking clarification for significant increase in the Volume of our Security across the Exchanges. In this regards, we wish to inform you that all the material information / announcement that may have bearing on the operations / performance of the Company which include all the necessary disclosures in accordance with regulation 30 of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015 and under insider trading regulation, have always been disclosed by the Company within stipulated time and the same is available in public domain. There is no pending information or announcements which have a bearing on increase in volume of security of the Company.29-12-2021
Eris Lifesciences Ltd - 540596 - Clarification sought from Eris Lifesciences Ltd
The Exchange has sought clarification from Eris Lifesciences Ltd on December 29, 2021, with reference to Movement in Volume.The reply is awaited.29-12-2021